Research Council Announcements: Grants

Grants announcements from the MassGeneral Hospital for Children Research Council.

Grants

Announcement: New Biographical Sketch Format Required for NIH and AHRQ Grant Applications Submitted for Due Dates on or after January 25th, 2015 

The revised forms and instructions are now available on the SF 424 (R&R) Forms and Applications page.

 ______________________________________________________________________

Caring for Dependents Travel Awards

The Center for Faculty Development (CFD) is pleased to announce the call for Caring For Dependent(s) (CFD) Travel Awards.  This $500 award* will help make travel to an academic/society meeting directly related to his/her academic advancement possible.  The award is open to faculty (at the Instructor and Assistant Professor level) who have plans to attend a professional meeting between October 2015 and March 2016. Funding is intended to help defray additional care costs that go above and beyond care needs, (e.g., extended day care, extended elder care, caregiver travel) while the faculty member is traveling.

The Application deadline is 4:00 pm, Wednesday, June 24, 2015.  Please click here for the online application. For further information regarding the application process, please e-mail cfd@partners.org.

*Amount is for incurred expenses up to a maximum of $500. Six awards will be available for this call. A lifetime maximum of two CFD Travel Awards ($1000 upper limit) per faculty member will be allowed.

 ______________________________________________________________________

Harrington Prize for Innovation in Medicine

The Harrington Prize for Innovation in Medicine, presented by the American Society for Clinical Investigation (ASCI) and the Harrington Discovery Institute at University Hospitals - part of The Harrington Project for Discovery & Development, honors the physician-scientist who has moved science forward with notable achievements in innovation, creativity and potential for clinical application.

 

This annual prize provides the awardee with:

  • An unrestricted $20,000 honorarium
  • The Harrington Prize Lecture, delivered at the ASCI/AAP Joint Meeting
  • A review, published in the Journal of Clinical Investigation

 

This prize requires Institutional Nomination; MGH is not limited in the number of nominees we can submit. If you are interested, please contact MGH ECOR at ecor@partners.org by July 17, 2015 to be considered. Please contact Erin McGivney if you have questions regarding this process.

Click here for more information.

 

 ______________________________________________________________________

Hyundai Hope On Wheels Quantum Grant

Hyundai Hope On Wheels (HHOW) is a 501(c)(3) non-profit organization that joined the fight against childhood cancer in 1998. The organization funds life-saving research and creates awareness for childhood cancer. Since its inception in 1998, HHOW has donated more than $100 million to fund pediatric cancer research in the U.S. Our mission is to increase awareness about the disease and to fund transformative research to increase cure and care.

In 2015, HHOW is pleased to announce a NEW category of grant awards for pediatric cancer. HHOW will make available four (4) $1,000,000 Hyundai Quantum Grant Awards, $250,000 per year for four years. The Hyundai Quantum Award is focused on funding transformational pediatric cancer research. The awards are aimed at funding research focused on childhood cancers with a poor prognosis.

 

Eligibility & Award Information

  • Research projects for the following pediatric cancers, which have low survival rates, will be considered:
    • Pediatric CNS tumors
    • Metastatic pediatric solid tumors
    • Pediatric myeloid leukemia.
  • The lead investigator must have an established record in pediatric cancer research, must be an MD or MD/PhD, and must commit to devoting at least 20% of his/her efforts to the project.
  • Applications must have demonstrable or potential translational relevance and impact.
  • Collaboration between multiple investigators (including a sub-award to another institution) is allowed.
  • Investigators can apply for a project that has grant funding from another source.
  • Clinical research trials – or correlative biological studies in a clinical trial –are not eligible for consideration.
  • Pediatric hematology research is not eligible.
  • Pathologists are not eligible to apply.

 

For more information, please view the RFP and the FAQs.

 

MGH is limited to only one applicant for this award. If you would like to be considered, please submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org no later than June 18, 2015. In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

  • Name of the Principal Investigator with appropriate contact information
  • A descriptive title of the potential application
  • Brief description of the project
  • Brief description of why you specifically should be selected to receive institutional nomination for this award focusing on relevance to pediatric cancer, quality of science, innovation, potential for success, potential impact on the field and demonstrated need for funding.

In the event that there is more than one MGH investigator interested in applying for a limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

 ______________________________________________________________________

MGH ECOR Formulaic Bridge Funding

What is it? Formulaic Bridge Funding Support is offered to assist MGH Principal Investigators during a lapse or delay in their funding from NIH. To be eligible for Formulaic Bridge Funding, applicants must have applied as a PI for an R01 or R21 grant to support an independent, long-term research program.

The Formulaic Bridge process is open to:

1. Investigators whose grants received a score < or = 20th percentile and have received written communication from the NIH that the grant will not be funded.

2. Investigators whose grants received a fundable score (< or = 20th percentile) but are 3 months past the nominal start date of the the grant.

When is the deadline? 7th day of each month.

 

How do I learn more and apply? Click here to read more and apply online.
Visit the ECOR website and specifically the Formulaic Bridge Funding Support under the Awards and Grants tab of the site.

 ______________________________________________________________________

HMS Foundation Funds

The Spring deadline for the HMS foundation funds has passed.  Please click here for general information on the HMS Foundation Funds.

______________________________________________________________________

 

Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email toecor@partners.org. In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

  • Name of the Principal Investigator with appropriate contact information
  • A descriptive title of the potential application
  • Brief description of the project
  • Brief description of why you specifically should be selected to receive institutional nomination for this award

In the event that there is more than one MGH investigators interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.

  • Advancing Health Disparities Interventions through Community-Based Participatory Research (U01)
  • Hyundai Hope On Wheels Quantum Grant – NEW!
  • NIAMS Rheumatic Diseases Research Resource-based Centers (P30)
  • Career Development Programs in Diabetes Research for Pediatric Endocrinologists (K12)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.

 

______________________________________________________________________

 

Private Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@partners.org if you wish to submit a proposal in response to any of these funding opportunities. Note that proposals are still routed through the standard InfoEd/Research Management process.

  • Biomedical Research Programs:  Faculty Scholars Program, Howard Hughes Medical Institute (HHMI)
  • Clinical Research Awards, Cystic Fibrosis Foundation (CFF)
  • Edward N. and Della L. Thome Memorial Foundation Awards Program in Alzheimer's Disease Drug Discovery Research, The Medical Foundation
  • Request for Applications, Foundation for Prader-Willi Research (FPWR)
  • PNH Research Grant, Aplastic Anemia & MDS International Foundation, Inc. (AA&MDSIF)
  • LE&RN/FDRS Lipedema Postdoctoral Fellowship Awards Program, Lymphatic Education & Research Network (LE&RN)

Please click here for further details on these funding opportunities.

 ______________________________________________________________________

 

PCORI

Please click here to find current grant opportunities from the Patient-Centered Outcomes Research Institute.

 

______________________________________________________________________

 

NIH Funding Opportunities

For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link:http://grants.nih.gov/grants/guide/WeeklyIndex.cfm

 

patient

What will we discover next?

Learn how researchers at MassGeneral Hospital for Children are finding new treatments that advance pediatric care.